Basel, Switzerland—Lonza has announced the adjustment of its Mid-Term Guidance 2022 to reflect the divestment of its former Water Care business unitand to emphasize its focus on growth along the Healthcare Continuum, apress release says.

Adjusted guidance is the following, according to the press release:
  • Sales of CHF 7.1 billion
  • CORE EBITDA margin of 30.5%
  • CORE RONOA 35%
  • Double-digit ROIC
Mark Funk, CEO of Lonza, said in the release, “This adjusted Mid-Term Guidance clearly demonstrates our focus on growing our businesses along the Healthcare Continuum while continuing to aim for operational excellence, productivity improvements, and attractive margins.”

The Mid-Term Guidance is based on the present business composition, the present macro-economic environment, current visibility, and constant exchange rates, the press release says.